Rezafungin Acetate Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 200 mg

Reference Brands: Rezzayo (USA)

Category: Anti-fungal

Product Description:

Rezafungin, marketed under the brand name Rezzayo by Melinta Therapeutics, is a next-generation echinocandin antifungal medication used for the treatment of invasive candidiasis, including candidemia. It is specifically indicated for adult patients in the United States who have limited or no alternative treatment options for these serious and potentially life-threatening fungal infections.

Rezafungin works by inhibiting the fungal enzyme β-(1,3)-D-glucan synthase, which is essential for the formation and maintenance of the fungal cell wall. Inhibition of this enzyme leads to cell wall instability and ultimately results in fungal cell death. The drug demonstrates potent activity against a broad range of Candida species, including strains that may be resistant to other antifungal therapies.

A key advantage of rezafungin is its extended half-life, which enables once-weekly intravenous dosing. This dosing schedule offers significant clinical and logistical benefits compared to daily echinocandin therapy, particularly for hospitalized or critically ill patients. Through its targeted mechanism of action and convenient dosing profile, Rezzayo represents an important advancement in the management of invasive fungal infections.